West Pharmaceutical Services (NYSE:WST – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday. Other analysts ...

Fifth Third Bancorp lifted its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 2.0% ...

EXTON, Pa. - West Pharmaceutical Services, Inc. (NYSE:WST), a company specializing in solutions for injectable drug ...

This was the stock's second consecutive day of losses.

The stock's fall snapped a two-day winning streak.

West Pharmaceutical Services, Inc. WST is well poised for growth, backed by the robust Proprietary Products segment and sustained strength in research and development (R&D). However, foreign ...

For instance, the price of West Pharmaceutical Services, Inc. (NYSE:WST) stock is up an impressive 121% over the last five years. Also pleasing for shareholders was the 12% gain in the last three ...

West Pharmaceutical Services, Inc. WST is well poised for growth, backed by the robust Proprietary Products segment and ...

Citi has initiated coverage of West Pharmaceutical Services (NYSE:WST), a provider of pharmaceutical packaging and injectable solutions, with a buy rating. The investment bank said it sees ...

EXTON, Pa., Jan. 30, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), global leader in innovative solutions for injectable drug administration, today announced that it will ...

West Pharmaceutical Services stock is down 16% on deteriorating fundamentals. WST's business is contracting, with lower sales growth, compressed margins, and declining ROIC, making current ...